Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.
about
Inflammasomes: too big to missThe complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particlesThe Relationship between NALP3 and Autoinflammatory SyndromesImproving the clinical impact of biomaterials in cancer immunotherapy.Molecular mechanisms regulating NLRP3 inflammasome activationChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesLighting the fires within: the cell biology of autoinflammatory diseasesPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesDynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunizationTreatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary KillingStructure of RiVax: a recombinant ricin vaccineAdjuvants for peptide-based cancer vaccinesInternational Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseSynthetic Nanoparticles for Vaccines and ImmunotherapyNLRP3 inflammasome activation induced by engineered nanomaterialsAnalysis of human innate immune responses to PRINT fabricated nanoparticles with cross validation using a humanized mouse modelEngineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticlesMetal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential ApplicationsNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesActivation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.Protective immunity to influenza: lessons from the virus for successful vaccine design.NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretionPneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.Application of nanotechnologies for improved immune response against infectious diseases in the developing worldEffective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2.Recent progress in adjuvant discovery for peptide-based subunit vaccinesToll-like receptor agonists: are they good adjuvants?Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccineBacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptorsWound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.The role of integrins in the recognition and response of dendritic cells to biomaterialsTargeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigenExposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation.Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer.Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.
P2860
Q24647337-7FF611EF-CE27-47AD-BC24-6016861DFE03Q26741584-CD43D8AC-6B2E-47F9-A3F2-06E9BEEB2825Q26749025-78E4169B-7CF7-4E0E-A035-39C118281CBAQ26766267-F75DD816-DD75-4681-A0DB-0C1E02EB751BQ26778556-623BEC30-6190-49B9-8ADE-FF5203183F20Q26783488-543E7619-C0FC-43B3-9FA2-7954927295ECQ26827163-720A3702-E1A8-4F1C-B65E-95B956032A53Q26852816-954A8BF9-811C-44C9-8335-821418EDDA11Q27320722-A8A7A0E1-D2B2-40A1-9332-CCEBE9249D4FQ27321663-0742FF8E-30E4-4A23-8D5F-B9C7751A6CB0Q27673488-E2D25B79-1350-40FC-BB5D-8C860743EF7FQ28072236-947266C1-3DFD-4539-B69B-C114D3498072Q28081406-A547D153-E0C7-4CCC-B7B7-DB96C6499600Q28085375-16741AE4-5292-4429-9795-52AB9278A929Q28387817-EEEAE907-696E-49A1-ABA4-708447811079Q28391210-DDF10A68-6005-4969-8F31-1715374A84CAQ28394668-563BDC04-6524-42EE-A6DF-92AC38AFB1E4Q28396375-14E6274F-3C6E-469C-91AE-189F1D4C105AQ29248417-05765F12-6635-4119-B68F-841A115DEE1BQ29615593-ADBA48C5-BC69-43EB-9997-CB603ABAE905Q30377729-C797648A-F5F5-48F0-9267-127729F6569EQ30446504-4163C61B-697A-4FB9-8821-7493469145B6Q33509292-E048F451-563B-447A-9065-B5CC9E16909CQ33640502-EA920429-440C-41F0-90B3-D2D89928D056Q33750041-9282CCFB-913A-4BAD-AE61-0A230AFE981FQ33786763-85936C5F-0A86-4612-9581-0F031C92A54AQ33894321-77C3F0FD-8F29-4AAD-8CDF-549DE5B10509Q33994533-5F076D3C-539D-4EB0-BD84-44D457EE08E2Q34033780-B0D5740B-225D-49BB-A8FF-74967FD363EDQ34067537-7019A5E2-4890-4DCB-A0E2-DB025AE2715AQ34157315-A0879136-A039-477C-89C2-852748825D08Q34186542-062A2067-093C-4AFB-8BCA-6D357E4449FAQ34385682-0E6D9399-AE76-438A-859F-A8CB909366B2Q34495686-1D43A125-EFD7-4A60-A915-1539872FB289Q34532116-E7D89A7A-5087-4092-919B-E5FD10C54249Q34572710-D86EA682-006F-4933-B883-56A5933D4D22Q34675068-B0491E9A-1789-4A4C-B2F1-ABA023B2F609Q34684708-5C0874F5-652D-4BC2-9A1E-35BD02FD4251Q34871657-388021B5-81C4-4126-80F5-41D32A95A9C5Q34993838-AEF4DD63-0C07-4AB0-BFCB-6062A88CA465
P2860
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@en
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@nl
type
label
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@en
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@nl
prefLabel
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@en
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@nl
P2093
P2860
P50
P356
P1476
Uptake of particulate vaccine ...... ivates the NALP3 inflammasome.
@en
P2093
Benjamin Claass
Darren Ruane
Derek T O'Hagan
Fiona A Sharp
Luke A J O'Neill
Manomohan Singh
Padma Malyala
P2860
P304
P356
10.1073/PNAS.0804897106
P407
P577
2009-01-12T00:00:00Z